While the FDA issued warnings against compounded semaglutide, as of now, compounding semaglutide or prescribing it isnt against the law if there is a shortage of medication
Beyond weight loss and glucose control, how do you see GLP-1 agonists being leveraged to treat other conditions, such as cardiovascular disease, chronic kidney disease, sleep apnea, or osteoarthritis
Rohan were exceptionally friendly and informative during my visit
Knowing that metastasis lies at the heart of cancer mortality, researchers have spent decades trying to identifyand defeatthe specific factors that enable rogue cells to break away from the primary tumor and colonize the rest of the body
Some patients report spending weeks or months working through authorization processes, only to face denial and appeals